Leiter A, Veluswamy RR, Wisnivesky JP. The global burden of lung cancer: current status and future trends. Nat Rev Clin Oncol. 2023;20:624–39. https://doi.org/10.1038/s41571-023-00798-3.
Bray F, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74:229–63. https://doi.org/10.3322/caac.21834.
Zheng RS, et al. Cancer incidence and mortality in China, 2022. Zhonghua Zhong Liu Za Zhi. 2024;46:221–31. https://doi.org/10.3760/cma.j.cn112152-20240119-00035.
Article CAS PubMed Google Scholar
Meyer ML, et al. Calls to action on lung cancer management and research. Oncologist. 2024. https://doi.org/10.1093/oncolo/oyae169.
Article PubMed PubMed Central Google Scholar
Colt HG, et al. Follow-up and surveillance of the patient with lung cancer after curative-intent therapy: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 2013;143:e437S-e454S. https://doi.org/10.1378/chest.12-2365.
Morrison EJ, et al. Emotional problems, quality of life, and symptom burden in patients with lung cancer. Clin Lung Cancer. 2017;18:497–503. https://doi.org/10.1016/j.cllc.2017.02.008.
Article PubMed PubMed Central Google Scholar
McEwen BS, Stellar E. Stress and the individual. Mechanisms leading to disease. Arch Intern Med. 1993;153:2093–101.
McEwen BS. Stress, adaptation, and disease. Allostasis and allostatic load. Ann N Y Acad Sci. 1998;840:33–44. https://doi.org/10.1111/j.1749-6632.1998.tb09546.x.
Article CAS PubMed Google Scholar
Carbone JT, Clift J, Alexander N. Measuring allostatic load: approaches and limitations to algorithm creation. J Psychosom Res. 2022;163:111050. https://doi.org/10.1016/j.jpsychores.2022.111050.
Thronicke A, et al. Health-related quality of life in patients with lung cancer applying integrative oncology concepts in a certified cancer centre. Evid Based Complement Alternat Med. 2020;2020:5917382. https://doi.org/10.1155/2020/5917382.
Article PubMed PubMed Central Google Scholar
Yin S, Njai R, Barker L, Siegel PZ, Liao Y. Summarizing health-related quality of life (HRQOL): development and testing of a one-factor model. Popul Health Metr. 2016;14:22. https://doi.org/10.1186/s12963-016-0091-3.
Article PubMed PubMed Central Google Scholar
Nevarez-Flores AG, Chappell KJ, Morgan VA, Neil AL. Health-related quality of life scores and values as predictors of mortality: a scoping review. J Gen Intern Med. 2023;38:3389–405. https://doi.org/10.1007/s11606-023-08380-4.
Article PubMed PubMed Central Google Scholar
Buckwalter JG, et al. Allostatic load as a complex clinical construct: a case-based computational modeling approach. Complexity. 2016;21:291–306. https://doi.org/10.1002/cplx.21743.
Wiley JF, Gruenewald TL, Karlamangla AS, Seeman TE. Modeling multisystem physiological dysregulation. Psychosom Med. 2016;78:290–301. https://doi.org/10.1097/psy.0000000000000288.
Article PubMed PubMed Central Google Scholar
Kobrosly RW, van Wijngaarden E, Seplaki CL, Cory-Slechta DA, Moynihan J. Depressive symptoms are associated with allostatic load among community-dwelling older adults. Physiol Behav. 2014;123:223–30. https://doi.org/10.1016/j.physbeh.2013.10.014.
Article CAS PubMed PubMed Central Google Scholar
Nelson KM, Reiber G, Kohler T, Boyko EJ. Peripheral arterial disease in a multiethnic national sample: the role of conventional risk factors and allostatic load. Ethn Dis. 2007;17:669–75.
Sonino N, Fava GA, Lucente M, Guidi J. allostatic load and endocrine disorders. Psychother Psychosom. 2023;92:162–9. https://doi.org/10.1159/000530691.
Hao B, et al. Association between allostatic load and adverse outcomes among older patients with heart failure with preserved ejection fraction. BMC Geriatr. 2023;23:360. https://doi.org/10.1186/s12877-023-04091-x.
Article PubMed PubMed Central Google Scholar
Xing CY, et al. Prediagnostic allostatic load as a predictor of poorly differentiated and larger sized breast cancers among black women in the women’s circle of health follow-up study. Cancer Epidemiol Biomarkers Prev. 2020;29:216–24. https://doi.org/10.1158/1055-9965.Epi-19-0712.
Article CAS PubMed Google Scholar
Akinyemiju T, et al. Association of allostatic load with all-cause and cancer mortality by race and body mass index in the REGARDS cohort. Cancers (Basel). 2020;12. https://doi.org/10.3390/cancers12061695.
Ye ZJ, et al. Effect of a mentor-based, supportive-expressive program, be resilient to breast cancer, on survival in metastatic breast cancer: a randomised, controlled intervention trial. Br J Cancer. 2017;117:1486–94. https://doi.org/10.1038/bjc.2017.325.
Article PubMed PubMed Central Google Scholar
Castagné R, et al. Allostatic load and subsequent all-cause mortality: which biological markers drive the relationship? Findings from a UK birth cohort. Eur J Epidemiol. 2018;33:441–58. https://doi.org/10.1007/s10654-018-0364-1.
Article CAS PubMed PubMed Central Google Scholar
Obeng-Gyasi S, et al. Association of allostatic load with overall mortality among patients with metastatic non-small cell lung cancer. JAMA Netw Open. 2022;5:e2221626. https://doi.org/10.1001/jamanetworkopen.2022.21626.
Article PubMed PubMed Central Google Scholar
Yang D, et al. Allostatic load and risk of all-cause, cancer-specific, and cardiovascular mortality in older cancer survivors: an analysis of the National Health and Nutrition Examination Survey 1999–2010. Aging Cancer. 2023;4:74–84. https://doi.org/10.1002/aac2.12064.
Article PubMed PubMed Central Google Scholar
Guan Y, et al. Association between allostatic load and breast cancer risk: a cohort study. Breast Cancer Res. 2023;25:155. https://doi.org/10.1186/s13058-023-01754-w.
Article PubMed PubMed Central Google Scholar
Hamidou Z, et al. Time to deterioration in quality of life score as a modality of longitudinal analysis in patients with breast cancer. Oncologist. 2011;16:1458–68. https://doi.org/10.1634/theoncologist.2011-0085.
Article PubMed PubMed Central Google Scholar
Bonnetain F, et al. Time until definitive quality of life score deterioration as a means of longitudinal analysis for treatment trials in patients with metastatic pancreatic adenocarcinoma. Eur J Cancer. 2010;46:2753–62. https://doi.org/10.1016/j.ejca.2010.07.023.
Brusniak K, et al. Measuring the time to deterioration for health-related quality of life in patients with metastatic breast cancer using a web-based monitoring application: longitudinal cohort study. JMIR Cancer. 2021;7:e25776. https://doi.org/10.2196/25776.
Article PubMed PubMed Central Google Scholar
Seeman TE, Singer BH, Rowe JW, Horwitz RI, McEwen BS. Price of adaptation–allostatic load and its health consequences. MacArthur studies of successful aging. Arch Intern Med. 1997;157:2259–68.
Musoro JZ, et al. Minimally important differences for interpreting EORTC QLQ-C30 change scores over time: a synthesis across 21 clinical trials involving nine different cancer types. Eur J Cancer. 2023;188:171–82. https://doi.org/10.1016/j.ejca.2023.04.027.
Coon CD, Schlichting M, Zhang X. Interpreting within-patient changes on the EORTC QLQ-C30 and EORTC QLQ-LC13. Patient. 2022;15:691–702. https://doi.org/10.1007/s40271-022-00584-w.
Comments (0)